Results 231 to 240 of about 158,321 (287)
This study examined the effect of MYD88L265P (myeloid differentiation primary response gene 88 mutation L265P) and/or CD79BY196 (cluster of differentiation 79B gene mutation Y196) on central nervous system (CNS) relapse in 270 patients with newly diagnosed diffuse large B‐cell lymphoma.
Tomotaka Suzuki+14 more
wiley +1 more source
Adrenal gland haemangioma, a rare entity difficult to differentiate from malignancy. [PDF]
López Gómez P+3 more
europepmc +1 more source
THE INFLUENCE OF THE GONADS AND ADRENAL GLANDS ON THE IMMUNE RESPONSE TO SKIN GRAFTS
Ralph J. Graff+2 more
openalex +1 more source
Neuroendocrine carcinoma of the adrenal gland: A rare case report and literature review. [PDF]
Rozidi ARS, Djatisoesanto W, Ridholia.
europepmc +1 more source
Target‐enriched enzymatic methylation sequencing (TEEM‐seq), a DNA methylation sequencing method using the Twist Human Methylome panel, shows comparable performance to array‐based tumor methylation profiling. The method is compatible with both frozen and formalin‐fixed paraffin‐embedded (FFPE) samples and is a viable approach to tumor methylation and ...
Quynh T. Tran+6 more
wiley +1 more source
Pseudocysts of the Adrenal Gland: A Systematic Review of Existing Scientific Literature From 2000 to 2023. [PDF]
Dar SA+8 more
europepmc +1 more source
Treatment options for immune‐related adverse events associated with immune checkpoint inhibitors
Abstract The immunotherapy revolution with the use of immune checkpoint inhibitors (ICIs) started with the clinical use of the first ICI, ipilimumab, in 2011. Since then, the field of ICI therapy has rapidly expanded — with the FDA approval of 10 different ICI drugs so far and their incorporation into the therapeutic regimens of a range of malignancies.
Yu Hua Chen+3 more
wiley +1 more source
Management of undifferentiated adrenal gland metastases from malignant melanoma: case report. [PDF]
Shortreed H, Burute N, Aseyev O.
europepmc +1 more source